McCarthy Sean A. 4
4 · CytomX Therapeutics, Inc. · Filed Aug 22, 2024
Insider Transaction Report
Form 4
McCarthy Sean A.
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2024-08-20+37,500→ 671,749 total - Exercise/Conversion
Performance Stock Units (PSUs)
2024-08-20−37,500→ 0 total→ Common Stock (37,500 underlying) - Sale
Common Stock
2024-08-20$1.23/sh−13,898$17,082→ 657,851 total
Holdings
- 93,158(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]Represents vesting of a Performance Stock Unit ("PSU") award initially granted on August 10, 2022.
- [F2]Includes 197,500 restricted stock units.
- [F3]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs reported herein.
- [F4]Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
- [F5]Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vested on December 17, 2023 upon achievement of a certain performance-based milestone. In connection with the vesting reported herein, the remaining 50% of the PSUs vested upon achievement of a certain performance-based milestone.